Skip to main content

Plasma Cell Dyscrasias

  • Book
  • © 2016

Overview

  • Documents the state of the art in the biology and treatment of plasma cell malignancies
  • Discusses advances in understanding of the responsible molecular mechanisms
  • Written by leading experts in the field
  • Includes supplementary material: sn.pub/extras

Part of the book series: Cancer Treatment and Research (CTAR, volume 169)

This is a preview of subscription content, log in via an institution to check access.

Access this book

eBook USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (16 chapters)

  1. Monoclonal Gammopathy of Undetermined Significance and Smoldering Myeloma

  2. Multiple Myeloma

  3. Primary Amyloidosis, Systemic Light Chain and Heavy Chain Diseases, Plasmacytoma

  4. Waldenstrom’s Macroglobulinemia

Keywords

About this book

This book provides a concise overview of the state of the art in the biology and treatment of plasma cell malignancies, a heterogeneous group of diseases primarily characterized by the presence of clonal plasma cells within the bone marrow or extramedullary sites. The plasma cell dyscrasias investigated include monoclonal gammopathy of undetermined significance (MGUS), multiple myeloma, plasmacytoma, immunoglobulin deposition diseases (primary amyloidosis and systemic light and heavy chain deposition diseases), and Waldenström’s macroglobulinemia. In the case of multiple myeloma, the coverage ranges from genomic aberrations and microRNAs to treatment for different patient groups, upcoming novel therapies, immunotherapy, and transplantation. The book reflects the significant research advances achieved in this field during the past few years, which have enhanced our understanding of the molecular mechanisms responsible for the pathogenesis of plasma cell dyscrasias.

Editors and Affiliations

  • Dept. of Medical Oncolgy/Hematology,, ASST-Spedali Civili di Brescia Dept. of Medical Oncolgy/Hematology,, Brescia, Italy

    Aldo M. Roccaro

  • Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA

    Irene M. Ghobrial

Bibliographic Information

  • Book Title: Plasma Cell Dyscrasias

  • Editors: Aldo M. Roccaro, Irene M. Ghobrial

  • Series Title: Cancer Treatment and Research

  • DOI: https://doi.org/10.1007/978-3-319-40320-5

  • Publisher: Springer Cham

  • eBook Packages: Medicine, Medicine (R0)

  • Copyright Information: Springer International Publishing Switzerland 2016

  • Hardcover ISBN: 978-3-319-40318-2Published: 11 October 2016

  • Softcover ISBN: 978-3-319-82078-1Published: 16 June 2018

  • eBook ISBN: 978-3-319-40320-5Published: 01 October 2016

  • Series ISSN: 0927-3042

  • Series E-ISSN: 2509-8497

  • Edition Number: 1

  • Number of Pages: VI, 361

  • Number of Illustrations: 2 b/w illustrations, 7 illustrations in colour

  • Topics: Hematology, Oncology, Molecular Medicine

Publish with us